Workflow
DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise
德康医疗德康医疗(US:DXCM) ZACKS·2025-07-31 21:51

Key Takeaways DXCM Q2 sales rose 15.2% to 1.16B,beatingestimates;U.S.andinternationalmarketsbothgrewdoubledigits.DXCMgrossmarginfell340bpsto60.11.16B, beating estimates; U.S. and international markets both grew double digits.DXCM gross margin fell 340bps to 60.1% on logistics costs; full-year gross margin guidance remains at 62%.DXCM raised 2025 revenue outlook to 4.6-$4.625B, citing new coverage wins and strong CGM demand momentum.DexCom, Inc. (DXCM) reported second-quarter 2025 adjusted earnings per share (EPS) of 48 cents, which beat the Zacks Consensus Estimate of 45 cents by 6.7%. The company reporte ...